Today Opportunities Markets Hot News AI Chat

EN

Tickwind

Read every tick. See where the market's blowing.

Product

Markets
Theme Zones
All stocks
Compare
Hot stocks
Opportunities
News
Discussion
Watchlist
What's new

Account

Settings
Newsletter
For writers
Contact
Log in
Sign up

Markets Theme Zones All stocks Compare Hot stocks Opportunities News Discussion Watchlist What's new Settings Newsletter For writers Contact Log in Sign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Gross margin — 10-Year History · Tickwind

Home/MLTX/Gross margin

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Gross margin

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) gross margin by fiscal year — reported gross profit divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to MLTX

Source: SEC XBRL filings · For reference only · Not investment advice

More MLTX financial trends

MLTX Revenue MLTX Net income MLTX Net margin MLTX Gross profit MLTX Operating income MLTX Operating margin MLTX Operating cash flow MLTX Free cash flow MLTX Capital expenditures MLTX Return on equity

MLTX Stock buybacks

MLTX Dividends paid

MLTX Total assets

MLTX Total liabilities

MLTX Shareholders’ equity

MLTX overview →